3Grossman SL, Lessem J. Mechanisms and clinical effects of thiazolidinediones[J]. Exp Opin Invest Drugs, 1997, 6:1025- 1040. 被引量：1
4Grinsell JW, Lardinois CK, Sewislocki A, et al. Pioglitazone attenuates baml and postprandial insulin concentrations and blood pressure in the spontaneously hypertenstive rat[J]. Am J Hypertens 2000. 13:370- 375. 被引量：1
5Hirose H, Kawai T, Yamamoto Y, et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes[ J ].Metabolism, 2002, 51:314 - 573. 被引量：1
7Giaccari A,Sorice G,Muscogiuri G.Glucose toxicity:the leading actor in the pathogenesis and clinical history of type 2diabetes mechanism and potentials for treatment[J].Nutr Metab Cardiovasc Dis,2009,19(5):365-377. 被引量：1
8Cryer PE.The barrier of hypoglycemia in diabetes[J].Diabetes,2008,57:3169-3176. 被引量：1
9Cryer PE.Elimination of hypoglycemia from the livers of people affected by diabetes[J].Diabetes,2011,60(1):24-27. 被引量：1
10Rosenstock J,Schwartz SL,Clark CM Jr,et al.Basal insulin therapy in type 2diabetes:28-week comparison of insulin glargine(HOE 901)and NPH insulin[J].Diabetes Care,2001,24(4):631-636. 被引量：1
